U.S. government will buy more of GlaxoSmithKline and Vir’s COVID antibody drug By: MarketWatch November 17, 2021 at 06:13 AM EST The Glaxo GSK and Vir VIR drug, sotrovimab, was granted emergency authorization by the Food and Drug Administration in May. Read More >> Related Stocks: Gsk Plc ADR Vir Biotechnology Inc
